$6.65 Million is the total value of Elefante Mark B's 82 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 5.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FISV | Sell | FISERV | $544,000 | +2.8% | 5,010 | -2.9% | 8.19% | -3.0% |
| CVS | CVS HEALTH | $527,000 | -7.9% | 5,510 | 0.0% | 7.93% | -13.1% | |
| JNJ | Buy | JOHNSON & JOHNSON | $434,000 | +13.3% | 3,585 | +1.4% | 6.53% | +6.9% |
| PG | PROCTER & GAMBLE | $364,000 | +3.1% | 4,295 | 0.0% | 5.48% | -2.8% | |
| MA | MASTERCARD | $349,000 | -6.9% | 3,970 | 0.0% | 5.25% | -12.2% | |
| MMM | Buy | 3M | $348,000 | +5.8% | 1,985 | +0.5% | 5.24% | -0.2% |
| ADP | AUTOMATIC DATA PROCESSING | $347,000 | +2.4% | 3,780 | 0.0% | 5.22% | -3.5% | |
| AAPL | Buy | APPLE INC | $331,000 | -11.3% | 3,472 | +1.5% | 4.98% | -16.3% |
| NSRGY | NESTLE SA ADR | $328,000 | +4.1% | 4,230 | 0.0% | 4.94% | -1.8% | |
| ATR | APTARGROUP | $327,000 | +0.9% | 4,135 | 0.0% | 4.92% | -4.8% | |
| NVS | Buy | NOVARTIS AG ADR | $314,000 | +21.2% | 3,810 | +6.1% | 4.73% | +14.3% |
| UTX | Buy | UNITED TECHNOLOGIES | $301,000 | +5.2% | 2,940 | +3.2% | 4.53% | -0.8% |
| CB | Buy | CHUBB LIMITED | $274,000 | +19.7% | 2,103 | +9.4% | 4.12% | +12.8% |
| XOM | Buy | EXXON MOBIL | $257,000 | +13.2% | 2,727 | +0.6% | 3.87% | +6.8% |
| GOOGL | Buy | ALPHABET INC CL A | $257,000 | -4.8% | 365 | +2.8% | 3.87% | -10.2% |
| SLB | SCHLUMBERGER | $243,000 | +7.5% | 3,070 | 0.0% | 3.66% | +1.4% | |
| ROK | ROCKWELL AUTOMATION | $237,000 | +0.9% | 2,065 | 0.0% | 3.57% | -4.9% | |
| PEP | PEPSICO | $236,000 | +3.1% | 2,232 | 0.0% | 3.55% | -2.8% | |
| UL | New | UNILEVER PLC NEW ADR | $215,000 | – | 4,465 | +100.0% | 3.24% | – |
| ABT | Buy | ABBOTT LABS | $207,000 | -0.5% | 5,285 | +6.4% | 3.12% | -6.2% |
| ORCL | ORACLE | $203,000 | 0.0% | 4,955 | 0.0% | 3.06% | -5.7% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FISERV | 19 | Q2 2020 | 8.8% |
| MASTERCARD | 19 | Q2 2020 | 8.4% |
| APPLE INC | 19 | Q2 2020 | 8.0% |
| ALPHABET INC CL A | 19 | Q2 2020 | 7.3% |
| JOHNSON & JOHNSON | 19 | Q2 2020 | 6.5% |
| PROCTER & GAMBLE | 19 | Q2 2020 | 7.1% |
| AUTOMATIC DATA PROCESSING | 19 | Q2 2020 | 6.5% |
| ABBOTT LABS | 19 | Q2 2020 | 5.6% |
| NESTLE SA ADR | 19 | Q2 2020 | 8.0% |
| NOVARTIS AG ADR | 19 | Q2 2020 | 6.5% |
View Elefante Mark B's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2020-07-28 |
| 13F-HR | 2020-05-07 |
| 13F-HR | 2020-01-15 |
| 13F-HR | 2019-11-06 |
| 13F-HR | 2019-07-24 |
| 13F-HR | 2019-05-02 |
| 13F-HR | 2019-01-24 |
| 13F-HR | 2018-10-15 |
| 13F-HR | 2018-07-30 |
| 13F-HR | 2018-04-24 |
View Elefante Mark B's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.